PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 51 filers reported holding PSYCHEMEDICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $130,000 | +16.1% | 23,460 | +26.4% | 0.00% | – |
| Q1 2020 | $112,000 | -26.8% | 18,560 | +11.1% | 0.00% | – |
| Q4 2019 | $153,000 | -3.2% | 16,710 | -3.7% | 0.00% | – |
| Q3 2019 | $158,000 | -12.7% | 17,350 | -3.3% | 0.00% | – |
| Q2 2019 | $181,000 | -43.1% | 17,950 | -20.8% | 0.00% | – |
| Q1 2019 | $318,000 | -19.7% | 22,650 | -9.3% | 0.00% | – |
| Q4 2018 | $396,000 | -15.6% | 24,968 | +0.2% | 0.00% | – |
| Q3 2018 | $469,000 | -5.6% | 24,917 | -3.5% | 0.00% | – |
| Q2 2018 | $497,000 | -9.3% | 25,825 | +0.6% | 0.00% | – |
| Q1 2018 | $548,000 | +1.5% | 25,680 | -2.3% | 0.00% | – |
| Q4 2017 | $540,000 | -3.4% | 26,280 | -13.4% | 0.00% | – |
| Q3 2017 | $559,000 | -1.1% | 30,350 | +34.1% | 0.00% | – |
| Q2 2017 | $565,000 | +88.3% | 22,630 | +51.4% | 0.00% | – |
| Q1 2017 | $300,000 | -33.9% | 14,950 | -18.7% | 0.00% | – |
| Q4 2016 | $454,000 | – | 18,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 301,282 | $4,227,000 | 3.76% |
| QUANTUM CAPITAL MANAGEMENT | 56,179 | $788,000 | 0.42% |
| Mill Road Capital Management LLC | 14,896 | $209,000 | 0.27% |
| Gs Investments, Inc. | 15,300 | $214,659,000 | 0.17% |
| North Star Investment Management Corp. | 84,948 | $1,192,000 | 0.14% |
| CRAWFORD INVESTMENT COUNSEL INC | 310,870 | $4,362,000 | 0.13% |
| RBF Capital, LLC | 78,495 | $1,101,000 | 0.13% |
| Uniplan Investment Counsel, Inc. | 123,339 | $1,730,000 | 0.11% |
| DEPRINCE RACE & ZOLLO INC | 274,416 | $3,850,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 446,074 | $6,258,000 | 0.07% |